BNP Paribas Financial Markets’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,623
Closed -$64K 4425
2017
Q4
$64K Buy
2,623
+1,695
+183% +$32.6K ﹤0.01% 3532
2017
Q3
$17.1K Buy
928
+16
+2% +$277 ﹤0.01% 3668
2017
Q2
$15.1K Buy
912
+850
+1,371% +$11.8K ﹤0.01% 3808
2017
Q1
$856 Sell
62
-42
-40% -$674 ﹤0.01% 3737
2016
Q4
$1.97K Sell
104
-319
-75% -$6.12K ﹤0.01% 3921
2016
Q3
$9.38K Buy
423
+134
+46% +$2.52K ﹤0.01% 3192
2016
Q2
$5.28K Buy
+289
New +$4.98K ﹤0.01% 3247
2016
Q1
Sell
-516
Closed -$8.7K 3386
2015
Q4
$8.7K Sell
516
-602
-54% -$10.2K ﹤0.01% 3259
2015
Q3
$20.1K Buy
1,118
+668
+148% +$14.9K ﹤0.01% 3309
2015
Q2
$11.6K Buy
450
+325
+260% +$8.22K ﹤0.01% 3301
2015
Q1
$2.74K Buy
+125
New +$2.7K ﹤0.01% 3410

BNP Paribas Financial Markets's ENTL Position: Q1 2018 in Review

BNP Paribas Financial Markets sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 2,623 shares — an estimated $64K sold.

BNP Paribas Financial Markets first reported a position in ENTL in Q1 2015 and held it in 11 quarters. The position peaked at $64K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • BNP Paribas Financial Markets reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2,623 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $64K.
  • BNP Paribas Financial Markets first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 11 quarters.
  • BNP Paribas Financial Markets's Entellus Medical, Inc. Common Stock position peaked at $64K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2018, filed 11 May 2018.